Skip to main content
Caplight Logo









WISE

WISE

Private
MilanHealthcare & Life Scienceshttps://wiseneuro.com/

Last Round

Series D

Jun 17, 2024

Total Funding Raised

$64.72M

Company Overview

WISE is a medical device company that develops a new generation of implantable leads for neuromonitoring, neuromodulation, and brain-machine interface (BMI).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Sensors, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

implantable electrodesneuromodulationneuromonitoringneurotechstretchable electrodesintraoperative neurophysiological monitoringIONMbrain-computer interfaceBCIspinal cord stimulationcortical electrodesneurosurgery toolsbrain-machine interfacingBMIECoG electrodesmedical deviceepilepsy monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

WISE Comparables

Compare WISE with similar companies based on industry and business-model similarity.

WISE comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PMT Corporation
81%
NeuroOne Medical Technologies Corp
80%
Neurosoft Bioelectronics
79%

WISE Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series DJun 17, 2024
Series COct 1, 2020
Series BMay 25, 2017
Series AJun 9, 2015
SeedNov 7, 2013

Key People

Founding team and executive leadership

Luca Ravagnan

CEO and co-founder

Founding Team

Stefano Magnetti

Chief Technology Officer, Director of Engineering, R&D

Executive Team

Giulia Salzano

Chief Financial Officer

Executive Team

WISE Investors

Notable investors and investment history

WISE investors
InvestorRounds
EUREKA! Venture SGRSeries D, Series C
Indaco Venture Partners SGRSeries D
European Investment Bank GroupSeries D
CDP Venture Capital SGRSeries C
b2ventureSeed, Series A
High-Tech GründerfondsSeries C, Seed, Series A, Series B
Principia SGRSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 30, 2024

    Monthly visitors grew 826% MoM, reaching 1.5K.

  • Jun 17, 2024

    $35M round with EUREKA! Venture SGR and Indaco Venture Partners.

WISE Filings

Explore SEC and related filing metadata, where available.

WISE filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about WISE's valuation, stock price, and market status.

Is WISE a public or private company?

WISE is a private company.

What is the current stock price of WISE?

WISE is a private company with no public stock price. No recent secondary market data is available.

How much is WISE worth (valuation)?

Valuation information for WISE is not publicly available.

Can I buy WISE stock?

WISE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was WISE's last funding round?

Funding round information for WISE is not publicly available.

Who are the main investors in WISE?

Investor information for WISE is not publicly disclosed.

Will WISE IPO soon?

No public IPO plans have been announced for WISE.

How can I track WISE secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor WISE's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMilan
Employee Range46
Year Founded2011
Last FundingJun 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?